|Articles|October 1, 2012 (Updated: November 15, 2020)
- Pharmaceutical Executive-10-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - October 2012
Lundbeck's Big Bet
Advertisement
Articles in this issue
over 13 years ago
PE, October 2012 Cover Imageover 13 years ago
Lundbeck: Bidding for the Stars and Stripesover 13 years ago
The Drug Vote 2012over 13 years ago
Your Local Competitor: A Threat in Emerging Markets?over 13 years ago
Reforming Pharma Marketingover 13 years ago
Three Ways to the Futureover 13 years ago
Country Report: Turkeyover 13 years ago
Stem Cells: A Promise Deferred?over 13 years ago
Richard Bergström — Europe's Medicine ManNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Patent Term Extension: Challenges with Defining and Claiming Approved Biologics
2
Novo Nordisk Invests $506 Million in Ireland Manufacturing Facility Expansion
3
Pharmaceutical Executive Daily: Novo Nordisk Commits $506 Million to Ireland Manufacturing Site
4
The Multi-Purpose Paradigm: Scaling AI ROI and De-Risking the Life Sciences Value Chain
5